By Josh White
Date: Wednesday 04 Jun 2025
LONDON (ShareCast) - (Sharecast News) - Abingdon Health announced on Wednesday that it has deepened its strategic relationship with US-based diagnostics firm Find Out From Home (FOFH), appointing company president Chris Yates as a director of FOFH.
The AIM-listed rapid test developer and manufacturer holds a 19% stake in FOFH through a service-for-equity arrangement, and was supporting the US company's product development and regulatory efforts.
Abingdon and FOFH are currently working on gaining regulatory approval for four self-test kits targeting sexually transmitted diseases, under a $2m contract announced in December.
In addition, the two companies were collaborating on the development of a further three STD tests.
At 1030 BST, shares in Abingdon Health were down 2.43% at 6.83p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 6.75p |
Change Today | -0.25p |
% Change | -3.57 % |
52 Week High | 11.50 |
52 Week Low | 5.75 |
Volume | 163,592 |
Shares Issued | 193.63m |
Market Cap | £13.07m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:30 | 20 @ 7.50p |
15:30 | 400 @ 6.50p |
15:30 | 73,206 @ 6.63p |
15:23 | 2 @ 7.50p |
15:20 | 73,206 @ 6.83p |
You are here: research